In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap

Sixty percent of survey participants with next-gen sequencers have an Illumina platform. Over the next 12 months, more than a third plan to bring in the HiSeq 2000, and more than a third the Ion Torrent PGM.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.